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Abstract
Anionic lipids act as signals for the recruitment of proteins containing cationic clusters to 
biological membranes. A family of anionic lipids known as the phosphoinositides (PIPs) are low 
in abundance, yet play a critical role in recruitment of peripheral proteins to the membrane 
interface. PIPs are mono-, bis-, or trisphosphorylated derivatives of phosphatidylinositol (PI) 
yielding seven species with different structure and anionic charge. The differential spatial 
distribution and temporal appearance of PIPs is key to their role in communicating information to 
target proteins. Selective recognition of PIPs came into play with the discovery that the substrate 
of protein kinase C termed pleckstrin possessed the first PIP binding region termed the pleckstrin 
homology (PH) domain. Since the discovery of the PH domain, more than ten PIP binding 
domains have been identified including PH, ENTH, FYVE, PX, and C2 domains. Representative 
examples of each of these domains have been thoroughly characterized to understand how they 
coordinate PIP headgroups in membranes, translocate to specific membrane docking sites in the 
cell, and function to regulate the activity of their full-length proteins. In addition, a number of 
novel mechanisms of PIP-mediated membrane association have emerged, such as coincidence 
detection – specificity for two distinct lipid headgroups. Other PIP-binding domains may also 
harbor selectivity for a membrane physical property such as charge or membrane curvature. This 
review summarizes the current understanding of the cellular distribution of PIPs and their 
molecular interaction with peripheral proteins.
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1. Phosphoinositides
Cellular lipid membranes are dynamic structures that contain >1000 different lipid species 
(van Meer 2005). This dynamic variety of lipids, which includes the phosphoinositides 
(PIPs)1, provides spatial and temporal signals to mediate and direct interactions with target 
proteins. PIPs are derived from phosphatidylinositol (PI), synthesized in the ER by a PI 
synthase enzyme, which utilizes CDP-diacylglycerol (DAG) and myo-inositol (Agranoff et 
al. 1958). PI is then transported from the ER by PI transfer proteins (Cockcroft et al. 2007; 
Ile et al. 2010) and possibly vesicular trafficking to different cellular membranes. Recently, 
the PI synthase enzyme was found localized in a highly mobile organelle originating from 
1Abbreviations:
ANTH AP180 amino-terminal homology
BAR Bin amphiphysin Rvs (BAR)
C2 protein kinase C conserved 2
ENTH epsin amino-terminal homology
FAPP1 Four-phosphate adaptor protein 1
FERM band 4.1, ezrin, radixin, moesin
FYVE Fab1, YOTB, Vac1, and EEA1
GOLPH3 Golgi phosphoprotein 3
KA1 kinase associated-1 domains
MIL membrane insertion loop
PA phosphatidic acid
PDZ postsynaptic density 95, disk large, zonula occludens
PH pleckstrin homology domain
PI phosphatidylinositol
PIP phosphoinositide
PKC protein kinase C
PDB Protein Data Bank
PM plasma membrane
PS phosphatidylserine
PTB phosphotyrosine binding (PTB)
PX Phox domain
TGN trans-Golgi network
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the ER (Kim et al. 2011). The discovery of this organelle harboring PI synthase suggests PI 
may be dynamically disseminated throughout the cell via this machinery.
Once PI is distributed it can be reversibly phosphorylated on the 3, 4, and/or 5 hydroxyl 
group yielding seven different PIP species (Figures 1 and 2). This includes the 
monophosphorylated (PI(3)P, PI(4)P, and PI(5)P) as well as the bis (PI(3,4)P2, PI(3,5)P2, 
and PI(4,5)P2) and triphosphorylated (PI(3,4,5)P3) forms (Figure 2). PI can vary from ~ 
10-20 mol% of total lipid in different cells and tissues (Nasuhoglu et al. 2002; Wenk et al. 
2003) while phosphorylated PIPs make up less than 1% of the total cellular lipid pool. 
Despite such low cellular concentrations of PIPs they regulate a large number of cellular 
processes including membrane trafficking, cell growth and survival, cytoskeletal dynamics, 
and chemotaxis (Di Paolo and De Camilli 2006; Falke and Ziemba 2014; Roth 2004; Balla 
2013). To date the PIP kinases and PIP phosphatases responsible for maintaining the cellular 
pools of PIPs have been shown to be expressed in the cytosol or at cellular sites of 
mammalian cells in a manner that directs the production of distinct pools of PIPs in the 
cytosolic leaflet of cellular organelles (Balla 2013) as well as in the nucleus (Balla 2013; 
Shisheva 2013). This distribution enables, at the molecular level, PIPs to selectively regulate 
membrane trafficking machinery, lipid transfer proteins, enzymes, ion channels, and 
endocytic and exocytic machinery (Balla 2013; Paolo and De Camilli 2006).
1.1 Cellular Distribution of Phosphoinositides
Phosphoinositides are enriched with polyunsaturated fatty acids at the sn-2 position and 
mainly contain 1-stearoyl and 2-arachidonoyl chains in the cellular setting. The 
arachidonoyl chain, which has four double bonds, can cause disruption of dense membrane 
packing as the acyl chain is kinked. The effects of lipid packing density by PIPs may 
influence interactions at the membrane interface as electrostatic interactions between 
peripheral proteins and loosely packed lipids have been shown to be stronger than that with 
more densely packed lipids (Bigay et al. 2012; Mesmin et al. 2007). When PIPs are mixed 
with other lipids in cellular membranes they can form PIP-enriched regions (Levental et al. 
2008; Redfern and Gericke 2004; Wang et al. 2014) that can be further stabilized by 
peripheral proteins that cluster PIPs (McLaughlin and Murray 2005; Saarikangas et al. 
2009). Clustering of PIPs may provide areas of the membrane interface to attract 
polycationic proteins and proteins with PI-binding domains. Overall, there is a lack of 
quantitative data in vitro and in cells on the clustering and mixing of lipids on PIP-binding 
proteins. We feel this is an emerging area of interest to pursue with future biophysical 
experiments and work by Kooijman and colleagues strongly suggest that lipid-lipid 
interactions (Graber et al. 2012; Graber et al. 2013) could play a profound role in the ways 
peripheral proteins associate with membranes. For instance, PI and PI(4,5)P2 cooperatively 
form mixed domains that may regulate the spatial organization of cell signaling events. 
Taking into account cellular distribution of PI and its rapid phosphorylation to PIPs, which 
can then be dephosphorylated back to PI these lipid mixtures may play an important role in 
regulating lipid kinases and phosphatases as well as peripheral proteins with anionic lipid 
selectivity of PIP specificity.
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PI(4,5)P2 and PI(4)P are the most abundant of the PIPs, enriched in the PM and Golgi, 
respectively, and make up ~0.2-1% of the cellular lipid pool (Balla et al. 1988; Di Paolo and 
De Camilli 2006; van Meer 2008; Hammond et al. 2009; Kutateladze 2010) with PI(4,5)P2 
estimated to be in the range of 5,000-20,000 molecules/μm2 of the PM cytosolic leaflet 
(Falkenburger et al. 2010). The other phosphoinositides such as PI(3)P and PI(3,4,5)P3 are 
found in even smaller quantities at ~20-30% and 2-5% the level of PI(4,5)P2, respectively 
(See Figure 1). The PM harbors ~20-30 mol% anionic lipids on its inner leaflet (McLaughlin 
et al. 2002; McLaughlin and Murray 2005; Vance and Steenbergen 2005) that creates an 
overall negative electric field that attracts peripheral membrane proteins with cationic 
patches (Olivotto 1996). The electronegativity of the PM is attributed to the enrichment of 
polyvalent phosphoinositides including PI(4,5)P2 (McLaughlin et al. 2002; McLaughlin and 
Murray 2005) and PI(3,4,5)P3 (Heo 2006), which make up a small fraction of phospholipids 
on the inner leaflet of the PM (See Figure 1 for a depiction of the cellular distribution of 
PIPs) as well as other anionic species. The most abundant anionic lipid in the cytosolic 
leaflet of the PM is phosphatidylserine (PS), which comprises nearly 15-20% of the inner 
leaflet (Vance and Steenbergen 2005; Leventis and Grinstein 2010). PS significantly 
contributes to the recruitment of polycationic proteins (McLaughlin and Murray 2005) as 
well as proteins containing a specific PS binding motif such as some C2 domains (Cho and 
Stahelin 2006) and viral proteins (Adu-Gyamfi et al. 2013). The presence of PS in the PM 
and more recently on the cytosolic face of endosomes and budding vesicles from the Golgi 
has been detected using the PS specific C2 domain from lactadherin (Yeung et al. 2008, 
Fairn et al. 2011). The presence of anionic lipids such as PS in combination with other lipid 
headgroups such as PIPs provides a mode of regulation for receptor proteins that bind 
weakly to just one anionic lipid. Additive and synergistic effects of either the anionic charge 
at the PM or the presence of two distinct binding sites on a receptor protein (e.g., PI(4,5)P2 
and PS) mediate the selective PM localization of these proteins.
Other examples of selective PI localization include PI(3)P, which is detected in early 
endosomes and PI(3,5)P2, a PI low in abundance found in early endosomes, late endosomes, 
and lysosomes (Li et al. 2013; McCartney et al. 2014). Recently, however, novel studies and 
methods have provided new insights into PIP localization. For instance, PI(4)P was found to 
be an important component of the PM cytosolic leaflet (Hammond et al. 2012; Nakatsu et al. 
2012) while PI(3)P was found in the lumen of the ER in the malaria parasite (Bhattacharjee 
2012) and in the smooth ER and Golgi of mammalian cells (Sarkes and Rameh 2010). The 
more enigmatic PI(5)P, which has emerged as a cytosolic and nuclear signal (Shisheva 
2013), has been detected in the plasma membrane and enriched in the smooth ER and/or 
Golgi (Sarkes and Rameh 2010). Because most PIPs are found both at basal levels in 
cellular membranes and can be modulated by various cellular stimuli these studies 
underscore the importance of novel tools and methods to dissect the real-time distribution of 
PIPs in live cells.
One new quantitative method for cellular PI(4,5)P2 analysis was recently developed by Cho 
and colleagues (Yoon et al. 2011). The common approach to map cellular localization of 
anionic lipids such as PS or PIPs has been to fuse a fluorescent protein (e.g., GFP) with a 
protein module that has high affinity and selectivity for the anionic lipid of interest (Varnai 
and Balla 2006; Yeung et al. 2006; Yeung et al. 2008; Fairn et al. 2011). The PI(4,5)P2-
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binding ENTH domain was first engineered for better membrane binding affinity and 
minimal affinity for cellular proteins. Through labeling with an environmentally sensitive 
chemical probe (2-dimethylamino-6-acyl-napthalene group) on a free cysteine, the 
engineered ENTH domain serves as a ‘turn-on’ sensor that undergoes a large increase in 
fluorescence upon lipid-binding. In addition, the probe undergoes a blueshift upon 
PI(4,5)P2-dependent membrane binding, which allows for ratiometric detection of PI(4,5)P2 
in vitro and in cells. The ratiometric approach allows researchers to overcome problems 
associated with fluorescently-tagged domains such as photobleaching or varying expression 
levels. The ENTH probe was able to be delivered to live cells by microinjection or 
liposome-mediated delivery and could robustly respond to PI(4,5)P2 fluctuations and detect 
the threshold level of PI(4,5)P2 required to trigger phagocytosis in immune cells. The 
approach designed by Cho and colleagues could be useful for other PIP signal detection as 
structural and functional knowledge of other PIP-binding domains are available and should 
allow engineering of lipid probes for other PIPs. While it may currently be difficult to sense 
both sides of membrane organelles using this chemical approach, it remains a considerable 
step forward in studying real-time PI signaling.
1.2 Cellular Manipulation of Phosphoinositides
Manipulation of cellular levels of phosphoinositides has been performed in various ways. 
These methods include overexpression of PIP phosphatases or kinases, PIP kinase selective 
inhibitors, monitoring translocation of fluorescently tagged PIP-binding domains, as well as 
direct chemical analysis of PIP levels (Suh and Hille 2007). Probably the most recent 
strategy of PIP manipulation has been the development of heterodimerization systems to 
selectively target cytosolic phosphatase domains to the cytoplasmic interface of cellular 
membranes to reduce PIPs and study the respective effects on peripheral proteins (Chang-
Ileto et al. 2012; Varnai et al. 2006). Below we will highlight the studies that have 
selectively modulated PIPs at the cytosolic interface of cellular membranes and organelles.
1.2.1 Plasma Membrane—Heo and colleagues demonstrated the effect of modulating 
PI(4,5)P2 levels in real time on the PM recruitment of certain GTPase proteins with 
polybasic clusters (Heo et al. 2006). One of the first targetable phosphatase depletion 
systems consisted of the PM-localizing FRB protein and the 5’-specific Inp54p phosphatase 
linked to the FKBP12 protein. Inp54p metabolizes PI(4,5)P2 into PI(4)P. Heterodimerization 
of FRB and FKBP12 was induced by the rapamycin analog, iRap. The authors determined 
that recruitment of Inp54p by indole rapamycin resulted in the dissociation of the PI(4,5)P2-
binding pleckstrin homology (PH) domain from the plasma membrane. However, PI(4,5)P2 
depletion did not result in the dissociation of proteins with polybasic motifs, suggesting 
another PIP plays a role in the docking of these proteins. Using a PI3K inhibitor 
(LY294002) that prevents PI(3,4,5,)P3 synthesis in concert with the PI(4,5)P2 depletion 
system, the authors concluded that both PI(4,5)P2 and PI(3,4,5)P3 serve as PM anchors for 
proteins with polybasic clusters. This strategy has also been used to study the selective 
gating of KCNQ ion channels by PI(4,5)P2 in the PM (Suh et al. 2006).
Chang-lleto et al. developed a system in COS-7 cells to hydrolyze PI(4,5)P2 at sites of 
plasma membrane tubule formation induced by the endophilin N-BAR domain (Chang-Ileto 
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et al. 2011). The N-BAR domain was fused to FRB and tagged with EGFP. The 5-
phosphatase domain of synaptojanin 1, important for clathrin-mediated endocytosis in the 
brain, was fused to the FKBP domain with an mRFP tag. This phosphatase converts 
PI(4,5)P2 into PI(4)P. This approach enabled the demonstration that acute conversion of 
PI(4,5)P2 to PI(4)P resulted in the fragmentation and condensation of the tubules formed at 
the plasma membrane by the N-BAR domain. They also determined that dynamin is 
required for this fission process. These experiments indicate that conversion of PI(4,5)P2 to 
PI(4)P at these sites of membrane curvature induces membrane fission in a dynamin-
dependent manner.
Use of the rapamcyin inducible system has shown that PI(4)P and PI(4,5)P2 are independent 
determinants of plasma membrane identity with both serving an important signaling role 
(Hammond et al. 2012). In this study a chimera was generated in which two enzymes were 
fused to the recruitable FKBP fragment: inositol polyphosphate-5-phosphatase E (INPP5E), 
which converts PI(4,5)P2 to PI(4)P, and Sac1 phosphatase, which converts PI(4)P to PI. This 
allowed the authors to metabolize both PIPs at the PM simultaneously upon rapamycin 
addition. Three additional chimera were made harboring mutations to inactivate either 
INPP5E or Sac1 or both enzymes so that PI(4,5)P2 and PI(4)P levels in the PM could be 
modulated independently by these constructs in which only one or neither of the enzymes is 
active. The authors were able to employ this system to demonstrate that PI4P is not required 
to maintain the steady state PI(4,5)P2 pool at the PM. Additionally, they determined that 
PI(4)P and PI(4,5)P2 serve some common roles at the PM, namely, the control of non-
specific binding to the PM of polybasic peptides as well as the regulation of certain ion 
channels (TRPV1).
1.2.2. Endosomal and Lysosomal Pathway—Fili et al. utilized the inducible-
dimerization system described above to locally deplete PI(3)P at early endosomes in HeLa 
cells (Fili et al. 2006). Early endosomes were targeted with Rab5a fused to FKBP and 
EGFP. Addition of the rapamycin analogue (AP21967) induced the recruitment of the FRB 
construct containing a myotubularin phosphatase (MTM1) to the Rab5a targeting construct, 
where PI(3)P was converted to PI. Local depletion of PI(3)P at Rab5a-positive endosomal 
compartments resulted in microtubule-dependent tubularization of the endosomes and 
affected the endocytic sorting of certain receptors, providing insight into the specific 
functions of this lipid in endosome morphology and trafficking (Fili et al. 2006).
Dong et al. developed a rapamycin-induced heterodimerization system for the late 
endosome/lysosome to study the effects of rapid PI(3,5)P2 depletion on the release of 
calcium from the mucolipin transient receptor potential (TRPML) channel (Dong et al. 
2010). Calcium release is important for proper late endocytic trafficking. Their previous 
experiments showed that applying exogenous PI(3,5)P2 to isolated endolysosomes increased 
TRPML activity. However, in order to confirm that endogenous PI(3,5)P2 regulates this 
channel, they induced the acute depletion of PI(3,5)P2 in Cos-1 cells with an EGFP-FKBP-
Rab7 targeting construct and an RFP-FRB-MTM1 (myotubularin) recruitable cytosolic 
construct. MTM1 converts PI(3,5)P2 into PI(5)P. Upon rapamycin addition, the authors 
found that TRPML activity was significantly reduced, suggesting PI(3,5)P2 plays a 
prominent regulatory role in the release of calcium from endolysosomes.
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1.2.3 Golgi—A rapamycin-induced system that targets the Golgi has been successfully 
developed (Szentpeter et al. 2010). To target the Golgi, the C-terminus of the human type I 
Golgi protein, TGN38, was fused to the N-terminus of a FRB-CFP construct. The human 
Sac1 phosphatase enzyme that dephosphorylates PI(4)P was fused to an FKBP12-mRFP 
construct. In confocal microscopy assays, the authors demonstrated that upon addition of 
rapamycin to cells transfected with these constructs, the Sac1 phosphatase enzyme was 
recruited to the Golgi where it dephosphorylated PI(4)P within 10 minutes, as evidenced by 
the concomitant dissociation of a PH domain probe that binds PI(4)P. With this system, the 
authors were able to confirm that PI(4)P is responsible for the Golgi localization of several 
clathrin adaptors and that depletion of PI(4)P prevents vesicular transport to both the plasma 
membrane and to the late endosomes. Additionally, they were able to determine that PI4P 
contributes to the recovery of PI(4,5)P2 stores at the PM, a hitherto unrecognized function. 
The authors noted that high expression of the TGN38-FRB-CFP construct affected Golgi 
structure and integrity. The overexpression of PH domains (OSBP, FAPP1, OSH1, or 
CERT) also may affect Golgi morphology and required fine-tuned expression with a 
thymidine kinase promoter. Also of note, the activity of the enzyme prior to recruitment 
needs to be monitored to account for unintended activity elsewhere. Additionally, a dead 
kinase should be used to rule out nonspecific effects of recruiting high concentrations of 
overexpressed protein to the membrane interface. These factors need to be considered when 
developing a recruitable enzyme system.
1.2.4 Intracellular Organelle Targeting—Komatsu et al. have developed a rapamycin-
induced targeting systems to the PM, ER, Golgi, lysosome, and mitochondria (Komatsu et 
al. 2010). They have tested for targeting motifs that do not distort the targeted organelle of 
interest upon over-expression and have developed the following constructs: FRB-YFP-
Giantin and CFP-FKBP for the Golgi; FRB-MoA (Monoamine Oxidase A) and CFP-FKBP 
for mitochondria; CFP-FKBP-Cb5 (cytochrome b5) and YFP-FRB for the ER; LAMP-CFP-
FRB (lysosomal-associated membrane protein) and YFP-FKBP for lysosome; and Lyn11-
FRB and CFP-FKBP for the PM. Experiments were mainly carried out in HeLa cells. The 
authors changed the constituents of the constructs (e.g., either FKBP or FRB for the 
targeting construct) or the order of the constituents (e.g., attaching FKBP or FRB to either 
the N- or C-terminus of the fluorescent or targeting motifs) to optimize translocation 
efficiency. For application, the authors used targeting systems for the plasma membrane 
(FKBP-RasGEF and Lyn11-FRB) and the Golgi (FKBP-RasGEF and FRB-Giantin) to study 
the site-specific activation of the Ras signaling pathway (Komatsu et al. 2010). They showed 
that Ras activation at the PM, but not at the Golgi, results in actin remodeling. Additionally, 
they showed that Ras activation at the plasma membrane results in ERK phosphorylation in 
the nucleus while Ras activation at the Golgi results in ERK phosphorylation primarily at 
the Golgi, demonstrating a spatial compartmentalization of Ras activity.
1.3 Phosphoinositides in Health and Disease
Since many proteins that interact with PIPs are enzymes, the stereospecific recognition of PI 
headgroups has important functional consequences with regards to biological activity. 
Indeed, there are a number of cases where a disease is attributable to the abrogation of these 
properties (McCrea and DeCamilli 2009). For instance, SHIP2 is a 5-phosphatase that acts 
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on PI(3,4,5)P3 and has been shown to act as a negative regulator of insulin signaling (Wada 
et al. 2001). Overexpression of SHIP2 has been shown to promote insulin resistance 
(Kagawa et al. 2008; Wada et al. 2001). Some type 2 diabetic patients have been shown to 
harbor a 16 base pair deletion of SHIP2 (Marion et al. 2002) that may act to regulate 
messenger RNA as mechanistic studies have demonstrated that this 16 base pair deletion 
causes increased expression of SHIP2 (Marion et al. 2002). Additional polymorphisms of 
SHIP2 have been found correlated with hypertension, obesity, and hyperlipidemia, which 
are common characteristics of metabolic syndromes (Kaisaki et al. 2008).
Myotubularins are 3-phosphatase enzymes that dephosphorylate PI(3)P and PI(3,5)P2. 
Mutations in myotubularin 1 have been shown to induce myotubular myopathy, which is 
characterized by muscle weakness and can often be lethal in infancy (Herman et al. 1999). 
Charcot-Marie-Tooth Disease has been linked to mutations in two different myotubularin 
family members, MTMR2 and MTMR13 (Azedine et al. 2003; Bolino et al. 1996; Senderek 
et al. 2003). Patients with this disease have peripheral neuropathy and leg weakness due to 
misfolding of myelin sheaths, which presents in childhood and can often lead to the inability 
to walk by early adulthood.
Perhaps the most well studied cases of alterations in PI metabolism are linked to cancer and 
mutation of the 3-phosphatase that acts on PI(3,4,5)P3, protein phosphatase and tensin 
homolog deleted on chromosome ten (PTEN). PTEN is a tumor suppressor known to be 
mutated in many cancers including melanoma, lung cancer, colon cancer, thyroid cancer, 
breast cancer, and thyroid cancer (Carracedo and Pandolfi 2008) where its action as a tumor 
suppressor is diminished. As PTEN acts on PI(3,4,5)P3 to make PI(4,5)P2, the opposite 
effect of growth activating mutations in the PI3-kinases that convert PI(4,5)P2 to PI(3,4,5)P3 
has also been shown in lung, breast, ovarian, colon, and gastric cancer (Bader et al. 2005; 
Engelmann, J.A. et al. 2006). Accordingly, PI3-kinase inhibitors have shown promise as 
cancer therapeutics (Osaki et al. 2004).
PTEN is an interesting peripheral protein regulated by unique biophysical properties. PTEN 
has been shown to harbor a N-terminal binding site for PI(4,5)P2, binding to which induces 
increased α-helicity of PTEN (Redfern et al. 2008). Moreover, PTEN is selective for 
PI(4,5)P2 when compared to other PIPs, which helps explain PTEN localization to the inner 
leaflet of the PM where it dephosphorylates PI(3,4,5)P3. PTEN can also bind PS through its 
C2 domain (Shenoy et al. 2012; Gericke et al. 2013). Strikingly, the presence of PS and 
PI(4,5)P2 in the same membrane increases PTEN membrane affinity where they synergize to 
recruit PTEN to the membrane interface (Shenoy et al. 2012; Gericke et al. 2013). As noted 
earlier, PS and PI(4,5)P2 are the most abundant PM anionic lipids and their PM spatial 
organization is expected to regulate PTEN localization. Biophysical studies further suggest 
PTEN likely has multiple PI(4,5)P2 binding sites (Shenoy et al. 2012) although the distinct 
role of each site and how they each selective recognition of the PI(4,5)P2 headgroup is still a 
burning question. Continuations of these biophysical studies will likely yield very useful 
insight into the mechanisms regulating PTEN catalysis and how individual mutations in 
cancer patients may dysregulate membrane binding or membrane induced activation of 
PTEN.
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Bipolar disorder and schizophrenia have also been linked to regions of chromosomes that 
encode lipid kinases and phosphatases including a PI3-kinase (PIK3C2), PI4-kinase type III 
α (PIK4CA), a PI(4)P 5-kinase (PIP5K2A), and the phosphoinositide phosphatase 
synaptojanin 1 (Saito et al. 2001; Saito et al. 2003; Stopkova et al. 2003; Stopkova et al. 
2004). Alterations of Synaptojanin 1, a PI(4,5)P2 phosphatase, have also been linked to 
Alzheimer’s disease and Down Syndrome (Berman et al. 2005; Arai et al. 2002). 
Synaptojanin 1 levels in Down Syndrome patient’s have been shown to be increased while 
PI(4,5)P2 levels are decreased (Voronov et al. 2008).
Therapeutic intervention at the level of protein-PIP interactions may be useful in improving 
metabolic disease outcomes. In this vein, computational structural analysis of several PIP-
binding domains including C2 and PH domains has suggested that drug-like compounds 
could be developed to inhibit lipid binding (Jo et al. 2011; Segers et al. 2007). 
Bioinformatics and computational biology have also begun to play an important role in 
lipid-binding domain studies yielding predictions of potential lipid-binding proteins 
(Bhardwaj et al. 2006; Gallego et al. 2010), elucidating the role of electrostatics in lipid 
binding (Murray et al. 2005; Mulgrew-Nesbitt et al. 2006; Dalton et al. 2007), and enabling 
the assembly of databases that compile lipid-binding domain data and predictions of 
membrane binding properties (Bhardwaj et al. 2007; Silkov et al. 2011; Chen et al. 2012).
2. Phosphoinositide-Binding
The specific localization of PIPs provides cellular spatial organization for PIP-binding 
proteins to recognize specific subcellular locations. PIP-binding proteins are most often 
peripheral proteins, a collective term for proteins that reversibly translocate to cellular 
membranes. Peripheral proteins employ different strategies for reversible membrane 
interactions and many contain one or more modular domains with selective PIP-binding 
properties. These PIP-binding structural modules, also known as membrane-targeting 
domains, include protein kinase C (PKC) conserved 2 (C2) (Cho and Stahelin 2006; 
Corbalan-Garcia and Gomez-Fernandez 2014); pleckstrin homology (PH) (Lemmon 2007; 
Kutateladze 2010); Fab1, YOTB, Vac1, and EEA1 (FYVE) (Kutateladze 2010); Phox (PX) 
(Kutateladze 2010); epsin amino-terminal homology (ENTH) (Horvath et al. 2007); AP180 
amino-terminal homology (ANTH) (Legendre-Guillemin et al. 2004); Bin amphiphysin Rvs 
(BAR) (Mim and Unger 2012); band 4.1, ezrin, radixin, moesin (FERM) (Mani et al. 2011); 
phosphotyrosine binding (PTB) (Alajlouni et al. 2011); postsynaptic density 95, disk large, 
zonula occludens (PDZ) (Chen et al. 2012; Wawrzyniak et al. 2013); GOLPH3 (Golgi 
phosphoprotein 3) (Dippold et al. 2009; Wood et al. 2009), PROPPINs (Baskaran et al. 
2012); tubby (Santagata et al. 2001), and kinase-associated 1 (KA1) domains (Moravcevic et 
al. 2012). The PH domain was the first of these shown to bind PIPs (Rebecchi et al. 1992) 
and the subsequent modules identified above have been shown to have a range of selectivity 
for the seven PIP species (Cho and Stahelin 2005; Hurley 2006; Kutateladze 2010; Lemmon 
2008; Sudhahar et al. 2008; Stahelin 2009; Moravcevic et al. 2012). In addition to PIP-
binding regulating several key cellular processes, abnormalities in PIP metabolism (McCrea 
and De Camilli 2009) or mutation of PIP-binding proteins can contribute to the etiology of 
disease (Carpten et al. 2007; Duning et al. 2013).
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2.1 PIP Binding Assays
Many assays have been developed to qualitatively and quantitatively assess PIP-binding 
(Cho et al. 2001; Narayan and Lemmon 2006). These techniques have their individual 
caveats but for the most part can be used to accurately parse out PIP selectivity and affinity. 
Qualitative assays include lipid blots, which harbor the different PIPs spotted on 
nitrocellulose and can be used to get a preliminary assessment of PIP selectivity. To more 
carefully investigate PIP selectivity, a number of centrifugation assays have been used 
where vesicles or beads containing different PIPs are sedimented to separate free and bound 
protein. Additionally, membrane flotation assays are available that can similarly isolate free 
and bound protein using centrifugation and a sucrose gradient. Isothermal titration 
calorimetry (Bravo et al. 2001), FRET (Nalefski et al. 2001; Landgraf et al. 2008; Lyakhova 
and Knight 2013) and light scattering (Connell et al. 2008) have also been useful in 
measuring lipid affinity and selectivity. Kinetic and equilibrium binding analysis has been 
performed using surface plasmon resonance to elucidate PIP selectivity and affinity 
(Stahelin et al. 2002; Stahelin et al. 2003a; Stahelin et al. 2003b; Narayan and Lemmon 
2006; Silkov et al. 2011; Yoon et al. 2012; Stahelin 2013). Although the above assays have 
provided robust analysis of PIP binding for peripheral proteins the field is still in need of 
rapid and stout global approaches for assessing PIP selectivity. This is especially true for 
newly or previously unidentified PIP-binding proteins. One such approach was recently 
developed for proteins expressed with a GFP tag (Kim et al. 2013). Synthetic PIPs have also 
been useful for rapid screening of PIP-binding (Rowland et al. 2012) and cellular 
identification of PIP-binding proteins using PIP-activity probes and proteomics (Rowland et 
al. 2011). In fact, this is an emerging area of research and new assays to globally investigate 
PIP-binding proteins are nicely reviewed by Michael Best in this special issue (Best 2013).
2.2 PIP-Mediated Membrane Association
Membrane-protein recognition is governed by various types of biochemical interactions that 
are dependent upon the physicochemical properties of both protein and membrane. 
Subcellular membranes have different compositions of bulk lipids and both constitutive and 
transient levels of PIPs, which can facilitate the membrane targeting of peripheral proteins. 
Association of peripheral proteins to membranes containing PIPs can be driven by diffusion 
and electrostatic forces. Once the protein associates, which is typically through electrostatic 
interactions with the membrane interface, formation of more tightly bound complexes 
ensues stabilized by H-bonding, electrostatic bonds, and membrane penetration (Stahelin 
and Cho 2001; Cho and Stahelin 2005; Lemmon 2008; Moravcevic et al. 2012).
For the majority of PIP-binding proteins, both specific and nonspecific electrostatic 
interactions with PIPs enhance the ka of lipid-binding (Stahelin and Cho 2001) as observed 
for the promotion of the protein-protein complexes (Schreiber 2002). Selective PIP binding 
and membrane penetration stabilize the complex by reducing the kd (Stahelin et al. 2002; 
Stahelin et al. 2003a; Stahelin et al. 2003b; Hom et al. 2007; He et al. 2009). The initial 
membrane docking of peripheral proteins facilitates specific interactions with PIPs by 
reducing the dimensionality of the space through which the protein interacts with its lipid 
ligand. When a peripheral protein is in the cytoplasm it is in three dimensions whereas when 
the peripheral protein is bound to the cytosolic face of a membrane bilayer its 
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dimensionality is reduced to two dimensions as it can only effectively diffuse or scoot in the 
x- and y-plane. PIP-binding domains generally have low affinity for membranes containing 
anionic lipids devoid of their cognate PIP. Without PIP bound these domains are unable to 
sufficiently penetrate the membrane due to a high penalty of desolvation (Diraviyam et al. 
2003; Stahelin et al. 2002; Stahelin et al. 2003a; Stahelin et al. 2003b) and the PIP acts as an 
electrostatic switch by reducing the desolvation penalty and inducing the membrane 
penetration of hydrophobic and aromatic residues that surround the PIP binding pocket. For 
instance, PI(4,5)P2 binding has been shown to play an important role in inducing the 
penetration of BAR domains (Yoon et al. 2012). The unique composition of each peripheral 
protein and/or PIP-binding domain as well as the target membrane provide diverse abilities 
for protein’s to bind membranes with different specificities, affinities, and orientations.
2.3 Coincidence Detection
Integration of dual lipid signals can provide a mechanism of more fine tuned regulation of 
peripheral proteins. For instance, the requirement of two distinct lipid-binding sites within 
the C2, PH, and PX domains has been demonstrated for enhanced localization to the plasma 
membrane (Gallego et al. 2010; Karathanassis et al. 2002; Lemmon 2008; Lucas and Cho 
2011; Moravcevic et al. 2012; Scott et al. 2012). This mode of dual lipid recognition termed 
“coincidence detection” (Balla 2005; Lemmon 2008; Moravcevic et al. 2012) is seen for 
plasma membrane PI(4,5)P2 and PS, which coordinate different sites in the C2 domain of 
PKCα (Guerrero-Valero et al. 2009; Corbalan-Garcia and Gomez-Fernandez 2014) and full-
length PTEN (Shenoy et al. 2012; Gericke et al. 2013). PI(4,5)P2 as well as other PIPs 
(Manna et al. 2008) can associate with a cationic patch that is exposed on the β-groove of 
some C2 domains (Cho and Stahelin 2006; Guillen et al. 2013; Corbalan-Garcia and 
Gomez-Fernandez 2014) while PS is engaged in three points of contact with the C2 domain 
as well as bridging with one of the bound Ca2+ ions (Verdaguer et al. 1999; Corbalan-Garcia 
and Gomez-Fernandez 2014). The presence of a PS and a PI-binding site in this C2 domain 
provides higher affinity and selectivity for the PM to which PKCα can rapidly bind when 
cytosolic Ca2+ levels increase. In addition, the PH domains of Akt1 and PDK-1 bind to both 
PI(3,4,5)P3 and PS (Huang et al. 2011; Lucas and Cho 2011). Cellular studies have 
demonstrated that both of these lipid-binding sites are important for their PM recruitment 
and furthermore, that the PS binding of the PDK1 PH domain is important in enhancing 
phosphorylation of Akt1 to its active form (Lucas and Cho 2011). Finally, PX domains also 
have been shown to bind both PIPs and other glycerophospholipids. The p47phox PX domain 
binds PI(3,4)P2 and uses a shallow pocket lined with basic residues to bind phosphatidic 
acid (PA) and to a lesser extent PS (Karathanassis et al. 2002).
Dual lipid recognition can enhance specific membrane targeting and may help to explain 
why a large number of lipid binding domains and peripheral proteins do not have high 
selectivity for one anionic membrane lipid such as a PIP (Moravcevic et al. 2012). A decade 
ago, comprehensive binding analysis of PH domains established that ~20% of PH domains 
from S. cerevisiae had remarkable affinity for PIPs (Yu et al. 2004). However, a recent 
large-scale analysis of lipid-binding domains in yeast has demonstrated that a number of 
these modules bind sphingolipids (Gallego et al. 2010). Sphingolipids have often been 
overlooked and not included in lipid-binding experiments, especially in combination with 
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PIPs. One recent study has demonstrated that the yeast PH domains from Slm1p or Yil105cp 
bound both PI(4,5)P2 and dihydrosphingosine-1-phosphate where both lipids were required 
for effective membrane localization (Gallego et al. 2010). For the most part, assays and 
methodologies have not been employed or developed to discover proteins that may bind 
PIPs and sphingolipids or those that may bind sphingolipids alone. This suggests that many 
lipid-binding domains should be carefully rescreened for sphingolipid binding to uncover 
new modes of membrane recognition that may have been overlooked. Indeed, coincidence 
detection by the C2 domain of cPLA2α for zwitteroinic lipids and the sphingolipid 
ceramide-1-phosphate (C1P) has recently been reported (Subramanian et al. 2005; Stahelin 
et al. 2007) where selective binding to C1P over PA is observed due to H-bonding with the 
C1P hydroxyl group (Ward et al. 2013). For cellular transport of C1P the recently identified 
C1P transport protein was shown to recognize the acyl amide moiety of C1P (Simanshu et 
al. 2013), an interaction that may also provide selectivity for some sphingolipids when 
compared to their glycerophospholipid counterparts. Additionally, annexin A2 which has 
long been known to bind PS and PI(4,5)P2 was recently shown to bind C1P with even higher 
affinity than that of PS or PA (Hankins et al. 2012). Other proteins have also recently been 
identified that bind ceramide (Saddoughi et al. 2013) as well as phosphorylated 
sphingolipids (Lamour et al. 2011).
In addition to dual lipid recognition, coincidence detection through a protein-protein 
interaction site in addition to a protein-lipid interaction site can also occur. Four-phosphate 
adaptor protein 1 (FAPP1) and OSBP bind PI(4)P and small GTPases at the Golgi 
membrane. The FAPP1 PH domain binds PIPs, with selectivity for PI(4)P (Lenoir et al. 
2010; He et al. 2011; Stahelin et al. 2007) and can also associate with Arf1 through a non-
overlapping binding site adjacent to the PIP binding pocket (He et al. 2011). It is thought 
that engagement of both PI(4)P and Arf1 is necessary for FAPP1 Golgi targeting as the PH 
domain has moderate affinity for PI(4)P-containing membranes and Arf1 can provide the 
second recruitment signal. Two or more binding sites provide either a platform to recruit 
peripheral proteins to specific cellular locations such as the PM where PS and PI(4,5)P2 
reside or a point of temporal control such as in the case of Akt1. In most cell types 
PI(3,4,5)P3 levels increase in the PS rich inner leaflet of the PM in response to various 
growth inducing stimuli, and thus Akt1 is recruited under specific temporal conditions 
(Huang et al. 2011). Coincidence detection of lipid and proteins also seems to be an 
important regulatory mechanism of PDZ (Chen et al. 2012; Wawrzyniak et al. 2013) and 
some C2 domains (Huang and Szebenyi 2010; Tian et al. 2011).
2.4 Other Considerations Regarding PI Binding
In addition to docking specific lipids, spatial recognition and regulation of membranes can 
be mediated by the degree of membrane curvature and by inherent differences in bulk lipid 
compositions among membrane organelles. Temporal regulation can also occur through 
metabolism of PIPs and DAG, influx of Ca2+ into the cytoplasm, and local membrane 
curvature changes induced by cell signaling processes. Moreover, a number of peripheral 
proteins are regulated in both a spatial and temporal fashion. For instance, proper targeting 
may require a certain degree of membrane curvature in addition to the presence of a 
temporally regulated lipid or two different lipids with docking sites on a single protein. 
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Recently, it was also demonstrated that some PI-binding domains could be regulated by pH. 
FYVE domains were the first module shown to target endosomes with higher affinity in an 
acidic environment due to protonation of histidine residues in the membrane-binding region 
(Lee et al. 2005; He et al. 2009). Protonation of His residues in acidic pH has been shown to 
promote higher affinity for lipid vesicles containing PIPs as well as cellular membranes for 
the PH domain of GRP1 (He et al. 2008) and the Epsin ENTH domain (Hom et al. 2007). 
Still unclear in pH-dependent PIP-binding, however, is the effect of protonation on PIPs. For 
instance, Kooijman, Gericke and colleagues have demonstrated that in acidic pH PIPs such 
as PI(4,5)P2 will undergo protonation (Kooijman et al. 2009). This effectively reduces PIP 
anionic charge and how His protonation on the peripheral protein may increase affinity for 
PIPs under these conditions is still not well understood.
3. Phosphoinositide binding modules
To date at least 14 PI-binding modules have been identified (See Table 1). These include: 
C2, PH, FYVE, PX, ENTH, ANTH, BAR, FERM, PTB, PDZ, GOLPH3, PROPPINs, tubby, 
and KA1 domains. These different families have varying affinity and selectivity for the 
seven PIPs. Below we discuss the FYVE, C2, and PH domains and the mechanisms that 
regulate their PI binding in biological membranes. Readers are also referred to other 
excellent reviews on PIP binding proteins (Lemmon 2008, Kutateladze 2010; Moravcevic et 
al. 2012) as well as more in depth reviews on specific PIP-binding domains such as BAR 
(Qualmann et al. 2011; Rao and Haucke 2011; Mim and Unger 2012), PDZ (Wawrzyniak et 
al. 2013), and PX (Kutateladze 2010; Teasdale and Collins 2012) domains. Additionally, 
table 1 has more relevant citations on various PIP binding domains that may be useful to the 
reader.
3.1 FYVE domains
FYVE domains are small (70 to 80 amino acid) cysteine-rich domains that bind two zinc 
ions and are found in at least 29 human proteins (Lemmon 2008; Letunic et al. 2009; 
Kutateladze 2010). These domains are highly homologous, and most FYVE domains 
specifically bind PI(3)P (Lemmon 2008; Kutateladze 2007; Kutateladze 2010)), although 
recently the FYVE domain of protrudin was shown to bind PI(4,5)P2, PI(3,4)P2, and 
PI(3,4,5,)P3 (Gil et al. 2012). Three motifs found in FYVE domains (WxxD, RR/KHHCR, 
and RVC) shape a cationic patch that interacts with PI(3)P. PI(3)P plays a key role in 
membrane trafficking and is found in specific subcellular locales, including the cytoplasmic 
face of early endosomes, multivesicular bodies, and phagosomes (Burd and Emr 1998; 
Gaullier et al. 1998; Patki V et al. 1998). In addition, PI(3)P has been shown to reside in the 
ER and Golgi apparatus (Sarkes and Rameh 2010), which may play a role in recruiting 
FYVE domain containing proteins DFCP1 and Alfy (Ridley et al. 2001; Simonsen et al. 
2004). In addition to their role in membrane trafficking, FYVE domain-containing proteins 
have been implicated in receptor signaling, actin cytoskeleton regulation, and neurite 
outgrowth. FYVE domains are also found in proteins that are involved in adipocyte 
differentiation, lipid kinases and phosphatases, ubiquitin ligases, and proteins involved in 
apoptosis and leukocyte signaling.
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3.1.1 Membrane-binding mechanism—FYVE domains use multiple mechanisms to 
achieve nanomolar affinity for PI(3)P-containing membranes. In addition to a cationic 
pocket that can selectively coordinate the PI(3)P headgroup, FYVE domains also engage in 
nonspecific electrostatic interactions that enhance their membrane association (Brunecky et 
al. 2005; Kutateladze et al. 2004; Stahelin et al. 2002). Specifically, the anionic lipid 
phosphatidylserine, which is found in appreciable concentrations on the cytoplasmic face of 
endosomes and multivesicular bodies can also contribute to FYVE domain membrane 
association and the orientation of the domain at the membrane interface (Brunecky et al. 
2005). Insertion of hydrophobic residues seems to be a general mechanism of membrane 
anchoring of the FYVE domain (Brunecky et al. 2005; Diraviyam et al. 2003; Stahelin et al. 
2002; Kutateladze et al. 2004; Kutateladze and Overduin 2001; Misra and Hurley 1999). 
The hydrophobic residues are found in a loop region that can vary in length and amino acid 
composition adjacent to the PI(3)P binding site. This loop region has also been dubbed the 
membrane insertion loop (MIL) (Kutateladze 2006; Kutateladze 2010). The MIL penetrates 
into the membrane after binding the PI(3)P headgroup, the effect of which is to elongate the 
membrane residence time of the protein (Stahelin et al. 2002). The FYVE domain has been 
shown to have a high desolvation penalty associated with loss of water molecules 
surrounding the MIL and in essence the PI(3)P binding to the FYVE domain acts as an 
electrostatic switch reducing the desolvation penalty associated with membrane insertion of 
the hydrophobic residues (Stahelin et al. 2002; Diraviyam et al. 2003). The MIL also harbors 
cationic residues that play a role in electrostatic interactions with acidic lipids at the 
membrane interface.
Perhaps the most interesting mode of FYVE domain association has to do with the local 
environmental pH as FYVE domains have two conserved His residues that interact with the 
inositol 3’-phosphate group. Acidic pH promotes the protonation of these His residues 
prompting PI(3)P binding in vitro and in cells (Lee et al. 2005; He et al. 2009) through 
enhanced interctions between protonated His and the PI(3)P headgroup. Additionally, 
deprotonation of these His residues has been shown to regulate release of the PI(3)P-
dependent membrane association (Lee et al. 2005; He et al. 2009). Dimerization of FYVE 
domain-containing proteins can also play an important role in enhancing the membrane 
affinity through concurrent interaction with two PI(3)P molecules (Dumas et al. 2001).
The first X-ray structure of a FYVE domain from yeast protein Vps27p (Protein Data Bank 
(PDB): 1VFY) revealed that it has a shallow pocket that putatively binds PI(3)P (Misra and 
Hurley 1999). The authors proposed that the FYVE domain binds to the membrane in a 
perpendicular “side-on” orientation, which would enable the binding of PI(3)P to the pocket 
and simultaneous interfacial penetration of two Leu residues (Leu185 and Leu186) in the 
MIL, a mechanism that was later supported by numerous biophysical studies (Brunecky et 
al. 2005; Diraviyam et al. 2003; Stahelin et al. 2002; Kutateladze et al. 2004; Kutateladze 
and Overduin 2001). Subsequent NMR studies of the FYVE domain of EEA1 in the 
presence (PDB: 1HYI) and absence (PDB: 1HYJ) of a soluble PI(3)P and/or lipid micelles 
suggest a membrane-binding mechanism in which nonspecific interfacial penetration 
precedes the binding of PI(3)P to its pocket (Kutateladze and Overduin 2001). The X-ray 
structure of EEA1-FYVE-inositol 1,3-bisphosphate complex demonstrates how the FYVE 
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domain stereospecifically recognizes the PI(3)P headgroup (Dumas et al. 2001). In addition 
to the aforementioned structures of FYVE domains additional ligand-free structures have 
been solved for Hrs (PDB: 1DVP), RUFY (PDB: 2YW8 and 2YQM), and Leishmania 
major Lm5-1 (PDB: 1Z2Q).
All FYVE domain structures that have been solved exhibit a similar overall fold consisting 
of two double-stranded antiparallel β-sheets and a C-terminal α-helix. The β1 strand harbors 
the RR/KHHCR motif, which is central to PI(3)P binding. The ligand bound structure of 
EEA1 (PDB: 1JOC) revealed that the last arginine in the motif (Arg1375) makes hydrogen 
bonds with the 3-phosphate along with the histidine residues, which used the imidazole ring 
(His1372) and backbone amide (His1373) to hydrogen bond with the 3-phosphate. The first 
two arginines of the motif (Arg1370 and Arg1371) interact with the 1-phosphate and 
important interactions are also observed between the 4-, 5-, and 6-hydroxyl groups of PI(3)P 
to promote specificity through exclusion of binding other PIPs.
Biophysical and computational studies of the FYVE domains have been used to elucidate 
the FYVE domain membrane-binding mechanism. Electrostatic potential calculations of 
Vps27p and Hrs FYVE domains showed that the MIL is surrounded by a positive 
electrostatic potential because of the presence of cationic residues in the PI(3)P binding site. 
This positive charge drives the initial membrane association (increasing the rate of 
association) (Stahelin et al. 2002; Cho and Stahelin 2005), which is followed by 
coordination of PI(3)P via electrostatic and H-bonds. PI(3)P binding then induces the 
penetration of the MIL as the desolvation penalty surrounding the MIL is reduced 
(Kutateladze 2010; Diraviyam et al. 2003; Stahelin et al. 2002; Cho and Stahelin 2005). 
Biophysical assays using SPR and monolayer penetration indicated that PI(3)P binding is 
required for the penetration of the MIL into the membrane. Thus, PI(3)P binding serves as 
an electrostatic switch, reducing the positive potential surrounding the MIL and promoting 
the penetration of hydrophobic residues (Diraviyam et al. 2003; Stahelin et al. 2002). 
Coordination of PI(3)P and penetration of hydrophobic residues elongate the membrane 
residence time (slower dissociation rate) and are thought to stabilize the membrane-bound 
complex. Computational studies of mulitple FYVE domains demonstrated they have 
different electrostatic potentials that can contribute to their membrane affinity and 
orientation at the membrane interface (Diraviyam et al. 2003). The membrane affinity of 
these different FYVE domains has also been shown to be an important factor in their 
subcellular localization (Blatner et al. 2004).
3.2 C2 DOMAINS
The C2 domain (~130 residues) (See Figure 3) like the C1 domain was first identified as one 
of two conserved regulatory domains in PKC (Ono et al. 1989; Osada et al. 1990) 
Identification of the C2 domain in other proteins, such as synaptotagmins and group IVA 
cytosolic phospholipase A2 (cPLA2α), which also bind membranes in a Ca2+-dependent 
manner, led to the postulation that the C2 domain is involved in Ca2+-dependent membrane 
binding. A large number of proteins containing the C2 domain have been identified since, 
and most of them are involved in signal transduction or membrane trafficking. The C2 
domain represents the second most abundant lipid-binding domain (following the PH 
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domain) with at least 200 examples identified. While most C2 domain proteins are 
peripheral and bind reversibly to membranes some C2 parent proteins are actually 
transmembrane proteins involved in membrane trafficking. However, these C2 domains can 
also bind reversibly in a Ca2+-dependent fashion (Davis et al. 2002).
3.2.1 C2 Domain Membrane Binding—The lipid affinity as well as the Ca2+ affinity of 
the Ca2+-binding C2 domains can vary greatly and some C2 domains are even involved in 
protein-protein interactions or may play a structural role. Ca2+ can play three different roles 
in membrane binding of the C2 domain: an electrostatic switch, a Ca2+-bridge, or inducing 
of intra- or interdomain conformational changes, which in turn trigger lipid binding. On the 
basis of the diverse Ca2+ affinity of C2 domains, peripheral proteins may be activated in a 
temporal manner depending upon the extent of the Ca2+ oscillations and their intensities. In 
other words, does their membrane association and dissociation distinctly follow the cellular 
Ca2+ oscillations under physiological conditions? While its been shown that enzymes such 
as PKC follow the Ca2+ spikes (Oancea and Meyer 1998), the disparate targeting of C2 
domains under the same cellular conditions are yet to be rigorously measured. A significant 
number of C2 domains with little to no Ca2+ affinity have also been identified. Some of 
these Ca2+-independent C2 domains have been reported to bind the membrane or other 
proteins (Cho and Stahelin 2006; Gericke et al. 2013). The general mechanism of how a 
number of C2 domains associate with membranes in a Ca2+-dependent fashion is well 
established (Nalefski et al. 2001; Cho and Stahelin 2006). However, physiological functions 
and Ca2+- and membrane-binding properties of a large portion of C2 domains still remain 
unknown. Structural studies have shown that C2 domains have a common fold of conserved 
eight-stranded antiparallel β-sandwich connected by surface loops (Shao et. al. 1996; Shao et 
al. 1998). The disparity in C2 domains targeting arises in the surface loops, which are 
variable in amino acid sequence and conformation and most often involved in lipid binding. 
Also of functional consequences is a cationic patch in the concave face of the β-sandwich 
termed the cationic β-groove, which varies in size and electrostatics among C2 domain (Cho 
and Stahelin 2006). In support of this observation, cationic β-grooves have been shown to 
bind PIPs including PI(4,5)P2 as well as C1P (Guerrero-Valero et al. 2009; Stahelin et al. 
2007; Ward et al. 2013). Thus, many C2 domains are able to coordinate multiple lipids in 
both a Ca2+-dependent or independent fashion. The preliminary data available on the 
multiple lipid recognition modes of C2 domains suggests C2 domains may be multiply 
regulated by different lipids and Ca2+ signals and in some cases may require coincidence 
detection (e.g., interaction with multiple lipid targets) to achieve high affinity and cellular 
localization (Corbalan-Garcia and Gomez-Fernandez 2014).
Most lipid binding domains achieve lipid specificity through a specific lipid-binding site 
formed within a pocket (e.g., C1, PH, PX, and FYVE domains) or with juxtaposed surface 
cationic residues (e.g., ANTH domain). C2 domains may be unique among lipid-binding 
domains in that they have neither a well-defined lipid-binding pocket nor a conserved 
cationic patch. The aforementioned sequence variation in the surface loops as well as the 
cationic β-groove leads to highly variable and relatively low lipid selectivity for some C2 
domains and high affinity and specificity for others (Cho and Stahelin 2006; Corbalan-
Garcia and Gomez-Fernandez 2014). Moreover, C2 domains can show different lipid 
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selectivity as a function of Ca2+ concentration because the relative contribution of two lipid-
binding sites can vary as PI-binding by the β-groove ligand may lower the Ca2+ requirement 
for lipid docking acting as an electrostatic switch in a similar mode to Ca2. A majority of 
Ca2+-dependent C2 domains harbor cationic residues in the Ca2+-binding loops and bind 
anionic lipids significantly better than zwitterionic ones. Some of these C2 domains bind 
anionic phospholipids through non-specific electrostatic interactions while others can 
stereospecifically recognize a lipid headgroup such as PS (Verdaguer et al. 1999; Stahelin et 
al. 2003c) or PI(3,4,5)P3 (Premkumar et al. 2010).
The cationic β-groove was first shown to interact with inositolpolyphosphates for the C2B 
domains of synaptotagmin II and IV (Fukuda et al. 1994; Fukuda et al. 1995). Thereafter, 
the C2B domains of synaptotagmin I (Schiavo et al. 1995) and II (Mehrotra et al. 2000) 
were shown to bind bis- and tris-phosphoinositides in a Ca2+-independent fashion. These 
first examples of cationic β-grooves do not have high lipid specificity but play a key role in 
the vesicle fusion activity of host proteins. The role of the cationic β-groove in PI-binding 
has been best characterized for PKCα (Guerrero-Valero et al. 2009; Manna et al. 2008). 
PKCα has been reported to bind PIPs including PI(4,5)P2 with nanomolar affinity (Manna et 
al. 2008). This binding is attributed to four lysine residues in the β-groove, which at first 
glance don’t seem to be enough to select PI(4,5)P2 over PI(3,4)P2, PI(3,4,5)P3 or other PIPs. 
In fact, experimental and computational investigation of the PKCα-C2 under various 
conditions found that PS and Ca2+ are a prerequisite for the PIP binding, which augments 
the PS binding by increasing the membrane residence time (Manna et al. 2008). PIP-binding 
for some C2 domains such as that of Tollip can exhibit broad specificity for PIPs (Ankem et 
al. 2011) and is regulated by protein-protein interactions with ubiquitin (Mitra et al. 2013).
These examples of PIP-binding in the β-groove of C2 domains should not only serve to 
understand the role of all β-grooves in C2 domains but may also be as a site of therapeutic 
intervention where the β-groove is required for coincidence detection or cellular activity. 
The disparate roles of this site in C2 domains may also serve as a better target than the more 
conserved Ca2+-binding sites and surface loop regions. Alternative splicing of some C2 
domains may also regulate their lipid and/or Ca2+-binding properties. The C2A domain of 
Dysferlin has been shown to have a canonical C2A and a variant (C2Av1) these two 
molecules have different Ca2+-binding properties and different ligand preferences (Fuson et 
al. 2013). In addition to diverse roles in Ca2+ selectivity and lipid-binding some C2 domains 
have been shown to induce membrane curvature changes upon membrane association 
(Martens et al. 2007; Hui et al. 2009; Ward et al. 2012; Yu et al. 2013; Sot et al. 2013). This 
biophysical property of some C2 domains may be important to vesicle trafficking and 
exocytosis as well as cellular localization and activity. More rigorous biophysical 
investigation of how C2 domains mediate this process is warranted to determine how they 
may be structurally akin to BAR and ENTH domains.
3.2.2. Rasal C2 Domains Generate and Sense Membrane Curvature—Rasal 
belongs to the Ras GTPase-activating protein (RasGAPs) GAP1 subfamily and has been 
shown to be epigenetically silenced in some cancers (Sot et al. 2013). Rasal contains tandem 
C2 domains (C2A and C2B) and its membrane recruitment, which is calcium-dependent has 
been shown to induce its RasGAP activity (Sot et al. 2013). The C2A domain of Rasal 
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specifically binds phosphatidylserine while the C2B domains interacts with several 
phosphoinositides including PI(3)P, PI(3,4)P2, PI(4,5)P2, and PI(3,4,5)P3 (Sot et al. 2013). 
These C2 domains are able to insert hydrophobic residues into the membrane and both 
generate and sense membrane curvature in a similar fashion to that of synaptotagmin (Hui et 
al. 2009; Martens et al. 2007) and Doc2b C2 domains (Yu et al. 2013). Lipid binding 
selectivity is also similar to the tandem C2 domain containing synaptotagmins and Rabphilin 
3A where PI binding by the Rasal C2B is most likely provided by cationic residues in the 
CBL2 in a similar fashion to the C2A domain of Rabphilin 3A C2A domain (Figure 3C). 
The Rasal C2 domains therefore provide a mode of temporal (Ca2+), spatial 
(phosphoinositides and the protein target Ras), and conformational (C2A and C2B 
interaction with membrane lipids) regulation. While Rasal C2 domain binding has been 
shown to be curvature dependent, its cellular role is not yet well understood. The authors of 
this study propose that Rasal C2 domain curvature-dependent binding may drive Rasal to 
cellular regions of high curvature to turn off Ras-GTP although their studies also 
demonstrated that Rasal activity is not increased in the presence of highly curved 
membranes (Sot et al. 2013).
3.2.3 KIBRA C2 Domain Phosphoinositide Binding—The human KIBRA gene has 
been linked to cognition and has been shown to harbor an intronic single-nucleotide 
polymorphism (SNP) associated with memory performance and the risk of development of 
Alzheimer’s disease. Strikingly, two common missense SNPs subsequently identified in 
KIBRA affect cognitive performance and encode variants of the KIBRA C2 domain. 
KIBRA is a cytoplasmic protein and member of the WWC1 (WW and C2-domain 
containing protein 1) family that has been shown to interact with dendrin and atypical PKC. 
The roles of the C2 domain of KIBRA are not well understood to date but several studies 
have implicated KIBRA in pathways such as vesicle based turnover, endosome vesicle 
sorting, directing cell migration, and establishment of cell polarity, all of which may require 
the KIBRA C2 domain to bind membranes. KIBRA C2 binds monophophosphorylated PIPs 
(PI(3)P) in a Ca2+-dependent fashion (Duning et al. 2013). These newly identified SNPs 
result in structural changes of the C2 domain (M734I and S735A) (Figure 3B) as well as a 
link to cognitive performance (Duning et al. 2013). In addition to binding PI(3)P like the 
WT allele, KIBRA mutants demonstrated increased affinity for PI(4)P and PI(5)P, which 
was comparable to that of PI(3)P binding. Additionally, KIBRA mutants bound to PI(4,5)P2 
in a similar fashion to that of monophosphorylated PIPs. While the cellular effects of these 
mutations on PIP-binding isn’t known, comparable affinity of KIBRA for PI(4)P, PI(5)P, or 
PI(4,5)P2 could lead to aberrant localization and temporal signaling.
3.2.4 Toxic Metals and C2 Domain Phosphoinositide Binding—Recently, the C2 
domain of PKCα was shown to bind Pb2+ with high affinity, which can compete with Ca2+ 
for an interaction with the C2 domain (Morales et al. 2011). Further structural studies using 
NMR revealed that Pb2+ and PI(4,5)P2 synergistically enhanced each others affinity for the 
C2 domain (Morales et al. 2012). PI(4,5)P2 binding to the PKCα C2 domain was able to 
enhance the C2 domain’s affinity for Pb2+ and the association of Pb2+ with membrane 
anionic sites (Morales et al. 2012). These results may have important implications to lead 
poisoning where excess lead in cells could lead to enhanced interactions with some C2 
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domains and biological membranes at low or resting concentrations of cytosolic Ca2+. On 
the other hand, Cd2+, which is also a toxic metal can form a strong complex with the 
membrane binding loops of the PKCα C2 domain but it is not sufficient for promoting 
membrane binding (Morales et al. 2013). In this case, toxic Cd2+ would inhibit proper 
regulation of PKCα by Ca2+ and membrane lipids.
3.3. PH Domains
The PH domain is composed of ~100 amino acids and is the most abundant lipid-binding 
domain with >250 examples identified and we refer you to several more detailed reviews on 
PH domains (Lemmon 2007; Lemmon 2008; Kutateladze 2010) (Figure 4). Of the seven PIs 
in the mammalian cell, the PH domain binds specifically to PI(3,4,5)P3, PI(4,5)P2, PI(3,4)P2 
(Lemmon 2007; Lemmon 2008; Kutateladze 2010; Moravcevic et al. 2012). Binding of PH 
domains to monophosphorylated PIPs seems to be less selective and have lower affinity than 
to that of bisphosphorylated PIPs (Yu et al. 2004; Lemmon et al. 2007; Stahelin et al. 2007; 
Prashek et al. 2013) and others may be coincident detectors for PIPs and sphingolipids or 
bind sphingolipids alone (Gallego et al. 2010). The membrane binding of PH domains is 
initially driven by non-specific electrostatic interactions, which is followed by specific PIP 
binding to achieve selective targeting and increase the membrane residence time. Like 
FYVE and some C2 domains, several PH domains anchor to the membrane through 
aliphatic residues adjacent to the PI-binding site (Kutateladze 2010; Lenoir et al. 2010; 
Moravcevic et al. 2012).
The majority of PH domains have a conserved basic motif (K-Xn-(K/R)-X-R) in which the 
basic lysines and arginines play an important role in forming H-bonds with the head group 
of the PI. Other basic residues located within the domain vary from domain to domain and 
can provide a stronger binding affinity and create a unique binding pocket. Two distinct 
members of the PH domain family (TIAM1 and ARHGAP9) (Ceccarelli et al. 2007) bind 
membranes through a site on the opposite side of the α1-αd2 loop suggesting that there are 
still novel PH domains to be discovered within the genome.
The importance of PH domains and disease was recently highlighted in an elegant study 
demonstrating an Glu to Lys (position 17) mutation in the AKT1 PH domain causes cancer 
(Figure 4). The E17K mutant was constitutively active due to pathological localization of 
E17K to the PM (Carpten et al. 2007). Falke and colleagues have shed some light on this 
pathological mechanism demonstrating that the PIP specificity of the AKT1 PH domain is 
drastically altered by the E17K mutation (Landgraf et al. 2008). Their biophysical analysis 
demonstrated E17K binds PI(4,5)P2 with even greater affinity than PIP3 and the constitutive 
PM localization of E17K may be due to binding to pools of PI(4,5)P2 often found in high 
concentration on the inner leaflet of the PM.
4. CONCLUSIONS AND FUTURE PERSPECTIVES
PIPs play important roles in the regulation of many cellular processes, including cell 
signaling and membrane trafficking (McCrea and De Camilli 2009). When these interactions 
are abolished or over-stimulated a number of life-threatening diseases can occur. 
Therapeutics aimed at the protein-lipid interface may serve as a viable means of achieving 
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high selectivity among targets. Achieving efficacy in abolishing the PI-dependent activation 
of the drug target or acting allosterically to promote protein ubiquitylation (Jo et al. 2011) 
are two avenues that have been explored. However, designing small molecule inhibitors of 
PIP-binding proteins is a challenging task, in part because the driving forces of protein-PIP 
association are a composite of many chemical interactions. Electrostatic forces, cation-π 
interactions, van der Waals forces, and hydrogen bonding all play a role in maintaining 
proper membrane function and in the association of proteins with biological membranes. We 
still have much to learn about the infusion of these forces into the processes of molecular 
design that will ultimately produce the compounds necessary to control biological events at 
the membrane interface. Nonetheless, recent studies demonstrate lipid-binding inhibitors can 
be designed that inhibit lipid-binding of C2 and PH domains (Jo et al. 2011; Segers et al. 
2007). In the case of the Akt1 PH domain inhibitor the effects are very unique (Jo et al. 
2011). This drug, SC66, is able to block PI(3,4,5)P3 binding by the PH domain but also 
facilitates an allosteric effect on Akt1 that promotes its ubiquitylation and destruction (Jo et 
al. 2011). The advent of better high-throughput screening, computational design, as well as 
enzyme and cell assays to assess drug efficacy will likely be necessary to expedite the 
discovery of small molecules in this field.
Progress in our understanding of the membrane binding mechanisms of PIP-binding proteins 
has been considerable over the past decade thanks to rapid progress in bioinformatics, 
computational biology, in vitro biophysical studies, structural biology, cellular imaging, and 
single molecule studies. Furthermore, proteomics and lipidomics has increased our 
awareness of the large number of PIP-binding proteins in nature (van Meer 2005; Clark et 
al. 2011; Rowland et al. 2011; Best 2013; Catimel et al. 2013; Oxley et al. 2013) some of 
which have potential therapeutic value or unique PIP-binding properties. The future research 
on PIP-binding interactions will encompass more interdisciplinary studies of both 
computational predictions and validations of these conjectures. Because many PIP-binding 
proteins have been discovered to act as coincident detectors, which often have low affinity 
for one lipid ligand and target cellular membranes through multivalent mechanisms it can be 
difficult to parse out the true lipids that mediate cellular recruitment and activation of PIP-
binding proteins. Some of the challenges that remain are the development of methods to 
resolve mechanisms of coincidence detection for peripheral proteins including those proteins 
that may bind sphingolipids in addition to PIPs.
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Figure 1. Cellular Distribution of PIPs
A cartoon of a cell is shown to illustrate the known location of PIPs in mammalian cells. 
The relative abundance of PIPs is depicted with the size of the star shown.
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Figure 2. There are seven different PIPs in mammalian cells that mediate recruitment of 
peripheral proteins to cellular membranes
The headgroup of each PI is shown with known effector domains listed below each.
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Figure 3. C2 domains have a β-sandwich structure with loop regions adjacent to the “cationic 
patch”
These structures have been crystallized with or without inositol headgroups and demonstrate 
PI-binding through interaction with positively-charged residues in the cationic patch region. 
PI-binding residues are depicted in blue. Dark blue residues represent positively charged 
lysines or argininges and light blue are other inositol-headgroup coordinating residues. 
Residues highlighted in magenta are PS-binding, residues highlighted in green are 
membrane-inserting, and residues highlighted in red are negative and calcium-coordinating. 
A. PKCα C2 (3GPE) coordinates PS with Asn189, Arg216, Arg249, and Thr251 where the 
sulfate is coordinated in the structure (orange and red spheres). In this loop region, 
negatively charged residues coordinate 3 calcium inos (green spheres) which are crucial to 
its membrane localization. The PIP2 headgroup is coordinated by Tyr195, Lys197, Lys209, 
Lys221, Trp245, and Asn253 in the cationic patch region. B. KIBRA C2 (2ZOU) harbors a 
cationic patch region with Arg753, His755, Arg714, Arg716, Lys692, and Arg696. In addition, 
Cys771 participates in a disulfide bond between two monomers in the structure. While the 
molecular basis of WT KIBRA binding to monophosphorylated PIPs such as PI(3)P is 
unknown, mutation of Met734 or Ser735 alters the C2 domain affinity in such a way it 
increases the affinity of the C2 domains for PI(4)P, PI(5)P, and PI(4,5)P2 (Duning et al. 
2013). C. Rabphilin C2A bound to IP3 (4NP9) coordinates the inositol headgroup in the 
cationic patch region using Tyr421, Lys423, His425, Lys435, Arg437 and Asn481.
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Figure 4. Pleckstrin Homology (PH) domains have a β-barrel structure with an alpha helical cap
These structures have been crystallized with either sulfate of inositol headgroups and 
demonstrate PI-binding at one end of the barrel with positively-charged residues and 
hydrophobic residues which insert into the membrane from the loop regions of the protein. 
PI-binding residues are depicted in blue. Dark blue residues are positively charged lysines or 
argininges and light blue are other inositol-headgroup coordinating residues. Residues 
highlighted in green insert themselves into the membrane from the loop regions, and 
residues highlighted in magenta are PS-binding. A. CERT PH (4HHV) coordinates a sulfate 
ion (orange and yellow spheres) in the inositol-binding region with Lys32, Thr34, Asn35, 
Arg43, Tyr54, Arg66 and inserts into the membrane with Trp33, Tyr36, Ile37, His38, Trp40. B. 
Akt PH (1UNQ) coordinates IP4 with Glu17, Arg23, Arg25, Asn52, and Arg86. It coordinates 
PS with Arg15 and Lys20. C. Akt PH (2UZS) is known to be converted to a constitutively 
active form in some cancers via mutation of Glu17 to Lys17 (highlighted by the black ovals 
in B and C).
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Table 1
PIP-binding domain selectivity, structure, and references.
Domain PIP Selectivity Structure References
ANTH PI(4,5)P2 as well as
PI(3,4,5)P3, PI(3,4)P2
for some.
Stahelin et al. 2003b; Silkov et al. 2011; Miller et al. 2011
BAR PI(4,5)P2, PI(4)P Peter et al. 2004;
Mim and Unger 2012; Yoon et al. 2012
C2 (Conserved
Kinase 2)
PI(4,5)P2 as well as
other PIPs
Cho and Stahelin 2006; Guerrero-Valero et al. 2009;
Ankem et al. 2011; Corbalan-Garcia and Gomez-Fernandez 2014
ENTH PI(4,5)P2 Ford et al. 2002;
Boucrot et al. 2012
FERM PI(4,5)P2 Edwards and Keep 2001; Carvalho et al. 2010
FYVE Majority PI(3)P
Protrudin FYVE:
PI(4,5)P2, PI(3,4)P2,
and PI(3,4,5,)P3
Dumas et al. 2001;
Kutateladze 2010;
Gil et al. 2012
GOLPH PI(4)P Wood et al. 2009;
Lenoir and Overduin 2013
KA1 (kinase
associated-1
domain)
Anionic lipids Moravcevic et al. 2010
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Domain PIP Selectivity Structure References
PDZ PI(4,5)P2 for some but
many are nonselective
Chen et al. 2012;
Wawrzyniak et al. 2013
PH (Pleckstrin
Homology)
Some selective for one
PIP while others are
nonselective.
PI(3,4,5)P3, PI(4,5)P2,
PI(3,4)P2, PI(3,5)P2,
PI(3)P, PI(4)P
Lemmon 2007;
Lemmon 2008;
Kutateladze 2010;
Moravcevic et al. 2012
PROPPINS PI(3,5)P2 and PI(3)P Baskaran et al. 2012
PTB PI(4,5)P2 Stolt et al. 2003
PX Mostly PI(3)P
Some: PI(4)P,
PI(4,5)P2, PI(3,4,5)P3, or
PI(3,4)P2
Bravo et al. 2001;
Karathanassis et al. 2002; Lemmon 2008; Kutateladze 2010; 
Moravcevic et al. 2012
TUBBY PI(4,5)P2 Santagata et al. 2001
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